Increased bone mineral density and serum leptin in non-obese girls with precocious pubarche: Relation to low birthweight and hyperinsulinism

Hormone Research

Volumn 54, Issue 4, 2000, Pages 192-197

  Ibáñez, Lourdes ^a   Potau, Neus ^b   Ong, Ken ^c   Dunger, David B ^c   De Zegher, Francis ^d  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Androgen; Birthweight; Bone mineral density; Insulin; Leptin; Precocious pubarche

Indexed keywords

ANDROGEN; INSULIN; LEPTIN;

ADOLESCENT; AGE DETERMINATION; ARTICLE; BIRTH WEIGHT; BLOOD; BODY MASS; BONE DENSITY; CHILD; FEMALE; GLUCOSE TOLERANCE TEST; HUMAN; HYPERINSULINISM; PATHOPHYSIOLOGY; PRECOCIOUS PUBERTY; REFERENCE VALUE;

ADOLESCENT; AGE DETERMINATION BY SKELETON; ANDROGENS; BIRTH WEIGHT; BODY MASS INDEX; BONE DENSITY; CHILD; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; HYPERINSULINISM; INSULIN; LEPTIN; PUBERTY, PRECOCIOUS; REFERENCE VALUES;

EID: 0034575063     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000053258     Document Type: Article

References (47)

1. Ibáñez L, Potau N, Carrascosa A: Androgens in adrenarche and pubarche; in Azziz R, Nestler JE, Dewailly D (eds): Androgen Excess in Women. Philadelphia, Lippincott-Raven, 1997, pp 73-84.
2. Ibáñez L, Potau N, Francois I, de Zegher F: Precocious pubarche, hyperinsulinism and ovarian hyperandrogenism in girls: Relation to reduced fetal growth. J Clin Endocrinol Metab 1998;83:3558-3662.
3. Ibáñez L, Potau N, de Zegher F: Precocious pubarche, dyslipidemia, and low IGF binding protein-1 in girls: Relation to reduced prenatal growth. Pediatr Res 1999;46:320-322.
4. Ibáñez L, de Zegher F, Potau N: Anovulation after precocious pubarche: Early markers and time course in adolescence. J Clin Endocrinol Metab 1999;84:2691-2695.
5. Ibáñez L, Potau N, Virdis R, Zampolli M, Terzi C, Gussinyé M, Carrascosa A, Vicens-Calvet E: Postpubertal outcome in girls diagnosed of premature pubarche during childhood: Increased incidence of functional ovarian hyperandrogenism. J Clin Endocrinol Metab 1993; 76:1599-1603.
6. Ibáñez L, Potau N, Zampolli M, Riqué S, Saenger P, Carrascosa A: Hyperinsulinemia and decreased insulin-like growth factor binding protein-1 are common features in prepubertal and pubertal girls with a history of premature pubarche. J Clin Endocrinol Metab 1997;82: 2283-2288.
7. Ibáñez L, Potau N, Chacón P, Pascual C, Carrascosa A: Hyperinsulinemia, dyslipaemia and cardiovascular risk in girls with a history of premature pubarche. Diabetologia 1998;41:1057-1063.
8. Ibáñez L, Potau N, Marcos MV, de Zegher F: Adrenal hyperandrogenism in adolescent girls with a history of low birthweight and precocious pubarche. Clin Endocrinol 2000;53:523-527.
9. Ibáñez L, Valls C, Potau N, Marcos MV, de Zegher F: Sensitization to insulin in adolescent girls to normalize hirsutism, hyperandrogenism, oligomenorrhea, dyslipidemia, and hyperinsulinism after precocious pubarche. J Clin Endocrinol Metab 2000;85:3526-3530.
10. Dhuper S, Warren MP, Brooks-Gunn, J, Fox R: Effects of hormonal status on bone density in adolescent girls. J Clin Endocrinol Metab 1990;71:1083-1088.
11. Hofbauer LC, Khosla S: Androgen effects on bone metabolism: recent progress and controversies. Eur J Endocrinol 1999;140:271-286.
12. Boot AM, de Ridder MAJ, Pols HAP, Krenning EP, de Muinck Keizer-Schrama SMPF: Bone mineral density in children and adolescents: Relation to puberty, calcium intake, and physical activity. J Clin Endocrinol Metab 1997;82:57-62.
13. Khosla S, Melton III LJ, Atkinson EJ, O'Fallon WM, Klee GG, Riggs BL: Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: A key role for bioavailable estrogen. J Clin Endocrinol Metab 1998;83:2266-2274.
14. Barret-Connor E, Kritz-Silverstein D: Does hyperinsulinemia preserve bone? Diabetes Care 1996;19:1388-1392.
15. Dagogo-Jack S, Al-Ali N, Qurttom M: Augmentation of bone mineral density in hirsute women. J Clin Endocrinol Metab 1997;82: 2821-2825.
16. Good C, Tulchinsky M, Mauger D, Demers LM, Legro RS: Bone mineral density and body composition in lean women with polycystic ovary syndrome. Fertil Steril 1999;72:21-25.
17. Thomas T, Gori F, Khosla S, Jensen MD, Burguera B, Riggs BL: Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. Endocrinology 1999;140:1630-1638.
18. Ogueh O, Sooranna S, Nicolaides KH, Johnson MR: The relationship between leptin concentration and bone metabolism in the human fetus. J Clin Endocrinol Metab 2000;85:1997-1999.
19. Saladin R, de Vos P, Guerre-Millo M, Laturque A, Girard J, Staels B, Auwerx J: Transient increase in obese gene expression after food intake or insulin administration. Nature 1995; 377:527-529.
20. Kolaczynski J, Nyce MR, Considine RV, Boden G, Nolan JJ, Henry R, Mudaliar SR, Olefsky J, Caro JF: Acute and chronic effect of insulin on leptin production in humans. Studies in vivo and in vitro. Diabetes 1996;45:699-701.
21. Kamoda T, Saitoh H, Nakahara S, Izumi I, Hirano T, Matsui A: Serum leptin and insulin concentrations in prepubertal lean, obese and insulin-dependent diabetes mellitus children. Clin Endocrinol 1998;49:385-389.
22. Brzechffa PR, Jakimiuk AJ, Agarwal SK, Weitsman SR, Buyalos RP, Magoffin DA: Serum immunoreactive leptin concentrations in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1996;81:4166-4169.
23. Laughlin GA, Morales AJ, Yen SCC: Serum leptin levels in women with polycystic ovary syndrome: The role of insulin resistance/hyperinsulinemia. J Clin Endocrinol Metab 1997;82: 1692-1696.
24. Mantzoros C, Dunaif A, Flier JS: Leptin concentrations in the polycystic ovary syndrome. J Clin Endocrinol Metab 1997;82:1687-1691.
25. Hammer LD, Kraemer HC, Wilson DM, Ritter PL, Dombusch SM: Standardized percentile curves of body mass index for children and adolescents. Arch Pediatr Adolesc Med 1991; 145:259-263.
26. New MI, Lorenzen F, Lerner AJ, Kohn B, Oberfield SE, Pollack MS, Dupont B, Stoner E, Levy DJ, Pang S, Levine LS: Genotyping steroid 21-hydroxylase deficiency: Hormonal reference data. J Clin Endocrinol Metab 1983;56: 3320-3325.
27. 5-steroid levels. J Clin Endocrinol Metab 1996;81:3961-3965.
28. del Rio L, Carrascosa A, Pons M, Gussinyé M, Yeste D, Domenech FM: Bone mineral density of the lumbar spine in white Mediterranean Spanish children and adolescents: Changes related to age, sex, and puberty. Pediatr Res 1994;35:362-366.
29. Greulich WW, Pyle SI: Radiographic Atlas of Skeletal Development of the Hand and Wrist. Stanford, Standford University Press, 1959, pp 125-183.
30. Potau N, Ibáñez L, Sentis M, Carrascosa A: Sexual dimorphism in the maturation of the pituitary-gonadal axis, assessed by gonadotropin-releasing hormone agonist challenge. Eur J Endocrinol 1999;141:27-34.
31. The Expert Committee on the Diagnosis and Classification of Diabetes mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes mellitus. Diabetes Care 1997;20:1183-1197.
32. Calvo MS, Eyre DR, Gundberg CM: Molecular basis and clinical application of biological markers of bone turnover. Endocr Rev 1996; 17:333-368.
33. Mora S, Pitukchheewanont P, Nelson JC, Gilsanz V: Serum levels of insulin-like growth factor I and the density, volume, and cross-sectional area of cortical bone in children. J Clin Endocrinol Metab 1999;84:2780-2783.
34. Hergenroeder AC: Bone mineralization, hypothalamic amenorrhea, and sex steroid therapy in female adolescents and young adults. J Pediatr 1995;126:683-689.
35. Boot AM, Engels ME, Boerma GJM, Krenning EP, de Muinck Keizer-Schrama SMPF: Changes in bone mineral density, body composition, and lipid metabolism during growth hormone (GH) treatment in children with GH deficiency. J Clin Endocrinol Metab 1997;82: 2423-2428.
36. Boot AM, de Muinck Keizer-Schrama SMPF, Pols HAP, Krenning EP, Drop SLS: Bone mineral density and body composition before and during treatment with gonadotropin-releasing hormone agonist in children with central precocious and early puberty. J Clin Endocrinol Metab 1998;83:370-373.
37. Adami S, Zamberlan N, Castello R, Tosti F, Gatti D, Moghetti P: Effect of hyperandrogenism and menstrual cycle abnormalities on bone mass and bone turnover in young women. Clin Endocrinol 1997;48:169-173.
38. Prior JC, Vigna IM, Schechter MT, Burgess AE: Spinal bone loss and ovulatory disturbances. N Engl J Med 1990;323:1221-1227.
39. Ibáñez L, Potau N, Marcos MV, de Zegher F: Treatment of hirsutism, hyperandrogenism, oligomenorrhea, dyslipidemia, and hyperinsulinism in nonobese, adolescent girls: Effect of flutamide. J Clin Endocrinol Metab 2000;85: 3251-3255.
40. Ibáñez L, Potau N, Marcos MV, de Zegher F: Exaggerated adrenarche and hyperinsulinism in adolescent girls born small for gestational age. J Clin Endocrinol Metab 1999;84:4739-4741.
41. Clayton PE, Gill MS, Hall CM, Tillmann V, Whatmore AJ, Price DA: Serum leptin through childhood and adolescence. Clin Endocrinol 1997;46:727-733.
42. Garcia-Mayor RV, Andrade MA, Rios M, Lage M, Dieguez C, Casanueva FF: Serum leptin levels in normal children: Relationship to age, gender, body mass index, pituitary-gonadal hormones, and pubertal stage. J Clin Endocrinol Metab 1997;82:2849-2855.
43. Klein KO, Larmore KA, de Lancey E, Brown JM, Considine RV, Hassink SG: Effect of obesity on estradiol level, and its relationship to leptin, bone maturation, and bone mineral density in children. J Clin Endocrinol Metab 1998;83:3469-3475.
44. Heger S, Partsch CJ, Peter M, Blum WF, Kiess W, Sippell WG: Serum leptin levels in patients with progressive central precocious puberty. Pediatr Res 1999;46:71-75.
45. Carmina E, Ferin M, Gonzalez F, Lobo RA: Evidence that insulin and androgens may participate in the regulation of serum leptin levels in women. Fertil Steril 1999;72:926-931.
46. Rouru J, Anttila L, Koskinen P, Penttilä TA, Irjala K, Huupponen R, Koulu M: Serum leptin concentrations in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1997;82:1697-1700.
47. Wabitsch M, Jensen PB, Blum WF, Christoffersen CT, Englaro P, Heinze E, Rascher W, Teller W, Tornqvist H, Hauner H: Insulin and cortisol promote leptin production in cultured human fat cells. Diabetes 1996;45:1435-1438.